Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:terminal state'
(id=6821902 ; fe=en:terminal state ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=8109 creation date=2017-06-25 touchdate=2025-10-12 17:30:16.000)
≈ 149 relations sortantes

  1. en:terminal state -- r_associated #0: 43 / 1 -> en:macrosomia
    n1=en:terminal state | n2=en:macrosomia | rel=r_associated | relid=0 | w=43
  2. en:terminal state -- r_associated #0: 43 / 1 -> en:meteoropathy
    n1=en:terminal state | n2=en:meteoropathy | rel=r_associated | relid=0 | w=43
  3. en:terminal state -- r_associated #0: 42 / 0.977 -> en:sick building syndrome
    n1=en:terminal state | n2=en:sick building syndrome | rel=r_associated | relid=0 | w=42
  4. en:terminal state -- r_associated #0: 41 / 0.953 -> en:foaming at mouth
    n1=en:terminal state | n2=en:foaming at mouth | rel=r_associated | relid=0 | w=41
  5. en:terminal state -- r_associated #0: 40 / 0.93 -> en:autoresuscitation
    n1=en:terminal state | n2=en:autoresuscitation | rel=r_associated | relid=0 | w=40
  6. en:terminal state -- r_associated #0: 40 / 0.93 -> en:irritability post vac
    n1=en:terminal state | n2=en:irritability post vac | rel=r_associated | relid=0 | w=40
  7. en:terminal state -- r_associated #0: 38 / 0.884 -> en:bloody discharge
    n1=en:terminal state | n2=en:bloody discharge | rel=r_associated | relid=0 | w=38
  8. en:terminal state -- r_associated #0: 38 / 0.884 -> en:unevaluable event
    n1=en:terminal state | n2=en:unevaluable event | rel=r_associated | relid=0 | w=38
  9. en:terminal state -- r_associated #0: 37 / 0.86 -> en:perforation
    n1=en:terminal state | n2=en:perforation | rel=r_associated | relid=0 | w=37
  10. en:terminal state -- r_associated #0: 35 / 0.814 -> en:body substance discharge
    n1=en:terminal state | n2=en:body substance discharge | rel=r_associated | relid=0 | w=35
  11. en:terminal state -- r_associated #0: 35 / 0.814 -> en:concomitant disease aggravated
    n1=en:terminal state | n2=en:concomitant disease aggravated | rel=r_associated | relid=0 | w=35
  12. en:terminal state -- r_associated #0: 35 / 0.814 -> en:critical illness
    n1=en:terminal state | n2=en:critical illness | rel=r_associated | relid=0 | w=35
  13. en:terminal state -- r_associated #0: 35 / 0.814 -> en:decreased exercise tolerance
    n1=en:terminal state | n2=en:decreased exercise tolerance | rel=r_associated | relid=0 | w=35
  14. en:terminal state -- r_associated #0: 35 / 0.814 -> en:difficulty standing
    n1=en:terminal state | n2=en:difficulty standing | rel=r_associated | relid=0 | w=35
  15. en:terminal state -- r_associated #0: 35 / 0.814 -> en:general signs and symptoms nec
    n1=en:terminal state | n2=en:general signs and symptoms nec | rel=r_associated | relid=0 | w=35
  16. en:terminal state -- r_associated #0: 35 / 0.814 -> en:hyperhidrosis
    n1=en:terminal state | n2=en:hyperhidrosis | rel=r_associated | relid=0 | w=35
  17. en:terminal state -- r_associated #0: 35 / 0.814 -> en:hypohidrosis
    n1=en:terminal state | n2=en:hypohidrosis | rel=r_associated | relid=0 | w=35
  18. en:terminal state -- r_associated #0: 35 / 0.814 -> en:infusion-related reaction
    n1=en:terminal state | n2=en:infusion-related reaction | rel=r_associated | relid=0 | w=35
  19. en:terminal state -- r_associated #0: 35 / 0.814 -> en:irritation
    n1=en:terminal state | n2=en:irritation | rel=r_associated | relid=0 | w=35
  20. en:terminal state -- r_associated #0: 35 / 0.814 -> en:local swelling
    n1=en:terminal state | n2=en:local swelling | rel=r_associated | relid=0 | w=35
  21. en:terminal state -- r_associated #0: 35 / 0.814 -> en:performance status decreased
    n1=en:terminal state | n2=en:performance status decreased | rel=r_associated | relid=0 | w=35
  22. en:terminal state -- r_associated #0: 35 / 0.814 -> en:stenosis
    n1=en:terminal state | n2=en:stenosis | rel=r_associated | relid=0 | w=35
  23. en:terminal state -- r_associated #0: 35 / 0.814 -> en:tissue anoxia
    n1=en:terminal state | n2=en:tissue anoxia | rel=r_associated | relid=0 | w=35
  24. en:terminal state -- r_associated #0: 34 / 0.791 -> en:adipose tissue deposition
    n1=en:terminal state | n2=en:adipose tissue deposition | rel=r_associated | relid=0 | w=34
  25. en:terminal state -- r_associated #0: 34 / 0.791 -> en:cold sweat
    n1=en:terminal state | n2=en:cold sweat | rel=r_associated | relid=0 | w=34
  26. en:terminal state -- r_associated #0: 34 / 0.791 -> en:concomitant disease progression
    n1=en:terminal state | n2=en:concomitant disease progression | rel=r_associated | relid=0 | w=34
  27. en:terminal state -- r_associated #0: 34 / 0.791 -> en:impaired self-care
    n1=en:terminal state | n2=en:impaired self-care | rel=r_associated | relid=0 | w=34
  28. en:terminal state -- r_associated #0: 34 / 0.791 -> en:induration
    n1=en:terminal state | n2=en:induration | rel=r_associated | relid=0 | w=34
  29. en:terminal state -- r_associated #0: 34 / 0.791 -> en:infected fistula
    n1=en:terminal state | n2=en:infected fistula | rel=r_associated | relid=0 | w=34
  30. en:terminal state -- r_associated #0: 34 / 0.791 -> en:microlithiasis
    n1=en:terminal state | n2=en:microlithiasis | rel=r_associated | relid=0 | w=34
  31. en:terminal state -- r_associated #0: 34 / 0.791 -> en:multiple organ failure
    n1=en:terminal state | n2=en:multiple organ failure | rel=r_associated | relid=0 | w=34
  32. en:terminal state -- r_associated #0: 34 / 0.791 -> en:premature aging syndrome
    n1=en:terminal state | n2=en:premature aging syndrome | rel=r_associated | relid=0 | w=34
  33. en:terminal state -- r_associated #0: 34 / 0.791 -> en:purulent discharge
    n1=en:terminal state | n2=en:purulent discharge | rel=r_associated | relid=0 | w=34
  34. en:terminal state -- r_associated #0: 34 / 0.791 -> en:sensitivity to weather change
    n1=en:terminal state | n2=en:sensitivity to weather change | rel=r_associated | relid=0 | w=34
  35. en:terminal state -- r_associated #0: 32 / 0.744 -> en:crying
    n1=en:terminal state | n2=en:crying | rel=r_associated | relid=0 | w=32
  36. en:terminal state -- r_associated #0: 32 / 0.744 -> en:dark circles under eyes
    n1=en:terminal state | n2=en:dark circles under eyes | rel=r_associated | relid=0 | w=32
  37. en:terminal state -- r_associated #0: 32 / 0.744 -> en:death imminent
    n1=en:terminal state | n2=en:death imminent | rel=r_associated | relid=0 | w=32
  38. en:terminal state -- r_associated #0: 32 / 0.744 -> en:disease prodromal stage
    n1=en:terminal state | n2=en:disease prodromal stage | rel=r_associated | relid=0 | w=32
  39. en:terminal state -- r_associated #0: 32 / 0.744 -> en:disuse syndrome
    n1=en:terminal state | n2=en:disuse syndrome | rel=r_associated | relid=0 | w=32
  40. en:terminal state -- r_associated #0: 32 / 0.744 -> en:influenza-like illness
    n1=en:terminal state | n2=en:influenza-like illness | rel=r_associated | relid=0 | w=32
  41. en:terminal state -- r_associated #0: 32 / 0.744 -> en:multimorbidities
    n1=en:terminal state | n2=en:multimorbidities | rel=r_associated | relid=0 | w=32
  42. en:terminal state -- r_associated #0: 32 / 0.744 -> en:obstruction
    n1=en:terminal state | n2=en:obstruction | rel=r_associated | relid=0 | w=32
  43. en:terminal state -- r_associated #0: 32 / 0.744 -> en:pneumatosis
    n1=en:terminal state | n2=en:pneumatosis | rel=r_associated | relid=0 | w=32
  44. en:terminal state -- r_associated #0: 32 / 0.744 -> en:wound discharge
    n1=en:terminal state | n2=en:wound discharge | rel=r_associated | relid=0 | w=32
  45. en:terminal state -- r_associated #0: 31 / 0.721 -> en:condition aggravated
    n1=en:terminal state | n2=en:condition aggravated | rel=r_associated | relid=0 | w=31
  46. en:terminal state -- r_associated #0: 31 / 0.721 -> en:developmental delay
    n1=en:terminal state | n2=en:developmental delay | rel=r_associated | relid=0 | w=31
  47. en:terminal state -- r_associated #0: 31 / 0.721 -> en:developmental regression
    n1=en:terminal state | n2=en:developmental regression | rel=r_associated | relid=0 | w=31
  48. en:terminal state -- r_associated #0: 31 / 0.721 -> en:fetal growth retardation
    n1=en:terminal state | n2=en:fetal growth retardation | rel=r_associated | relid=0 | w=31
  49. en:terminal state -- r_associated #0: 31 / 0.721 -> en:prolapse
    n1=en:terminal state | n2=en:prolapse | rel=r_associated | relid=0 | w=31
  50. en:terminal state -- r_associated #0: 31 / 0.721 -> en:serum sickness-like reaction
    n1=en:terminal state | n2=en:serum sickness-like reaction | rel=r_associated | relid=0 | w=31
  51. en:terminal state -- r_associated #0: 31 / 0.721 -> en:sucking, thumb
    n1=en:terminal state | n2=en:sucking, thumb | rel=r_associated | relid=0 | w=31
  52. en:terminal state -- r_associated #0: 31 / 0.721 -> en:symptom masked
    n1=en:terminal state | n2=en:symptom masked | rel=r_associated | relid=0 | w=31
  53. en:terminal state -- r_associated #0: 31 / 0.721 -> en:terminal agitation
    n1=en:terminal state | n2=en:terminal agitation | rel=r_associated | relid=0 | w=31
  54. en:terminal state -- r_associated #0: 31 / 0.721 -> en:xerosis
    n1=en:terminal state | n2=en:xerosis | rel=r_associated | relid=0 | w=31
  55. en:terminal state -- r_associated #0: 31 / 0.721 -> en:yellow complexion
    n1=en:terminal state | n2=en:yellow complexion | rel=r_associated | relid=0 | w=31
  56. en:terminal state -- r_associated #0: 30 / 0.698 -> en:effusion
    n1=en:terminal state | n2=en:effusion | rel=r_associated | relid=0 | w=30
  57. en:terminal state -- r_associated #0: 30 / 0.698 -> en:local reaction
    n1=en:terminal state | n2=en:local reaction | rel=r_associated | relid=0 | w=30
  58. en:terminal state -- r_associated #0: 30 / 0.698 -> en:night sweats
    n1=en:terminal state | n2=en:night sweats | rel=r_associated | relid=0 | w=30
  59. en:terminal state -- r_associated #0: 30 / 0.698 -> en:rales
    n1=en:terminal state | n2=en:rales | rel=r_associated | relid=0 | w=30
  60. en:terminal state -- r_associated #0: 30 / 0.698 -> en:reaction nonspecific
    n1=en:terminal state | n2=en:reaction nonspecific | rel=r_associated | relid=0 | w=30
  61. en:terminal state -- r_associated #0: 30 / 0.698 -> en:susceptibility
    n1=en:terminal state | n2=en:susceptibility | rel=r_associated | relid=0 | w=30
  62. en:terminal state -- r_associated #0: 29 / 0.674 -> en:disease complication
    n1=en:terminal state | n2=en:disease complication | rel=r_associated | relid=0 | w=29
  63. en:terminal state -- r_associated #0: 29 / 0.674 -> en:disease progression
    n1=en:terminal state | n2=en:disease progression | rel=r_associated | relid=0 | w=29
  64. en:terminal state -- r_associated #0: 29 / 0.674 -> en:exercise tolerance increased
    n1=en:terminal state | n2=en:exercise tolerance increased | rel=r_associated | relid=0 | w=29
  65. en:terminal state -- r_associated #0: 29 / 0.674 -> en:fistula discharge
    n1=en:terminal state | n2=en:fistula discharge | rel=r_associated | relid=0 | w=29
  66. en:terminal state -- r_associated #0: 29 / 0.674 -> en:inflammatory fistula
    n1=en:terminal state | n2=en:inflammatory fistula | rel=r_associated | relid=0 | w=29
  67. en:terminal state -- r_associated #0: 29 / 0.674 -> en:neonatal multi-organ failure
    n1=en:terminal state | n2=en:neonatal multi-organ failure | rel=r_associated | relid=0 | w=29
  68. en:terminal state -- r_associated #0: 29 / 0.674 -> en:peripheral swelling
    n1=en:terminal state | n2=en:peripheral swelling | rel=r_associated | relid=0 | w=29
  69. en:terminal state -- r_associated #0: 29 / 0.674 -> en:post cardiac arrest syndrome
    n1=en:terminal state | n2=en:post cardiac arrest syndrome | rel=r_associated | relid=0 | w=29
  70. en:terminal state -- r_associated #0: 29 / 0.674 -> en:pseudocyst
    n1=en:terminal state | n2=en:pseudocyst | rel=r_associated | relid=0 | w=29
  71. en:terminal state -- r_associated #0: 29 / 0.674 -> en:tissue adhesion
    n1=en:terminal state | n2=en:tissue adhesion | rel=r_associated | relid=0 | w=29
  72. en:terminal state -- r_associated #0: 28 / 0.651 -> en:administration related reaction
    n1=en:terminal state | n2=en:administration related reaction | rel=r_associated | relid=0 | w=28
  73. en:terminal state -- r_associated #0: 28 / 0.651 -> en:chronic disease
    n1=en:terminal state | n2=en:chronic disease | rel=r_associated | relid=0 | w=28
  74. en:terminal state -- r_associated #0: 28 / 0.651 -> en:disease recurrence
    n1=en:terminal state | n2=en:disease recurrence | rel=r_associated | relid=0 | w=28
  75. en:terminal state -- r_associated #0: 28 / 0.651 -> en:general symptom
    n1=en:terminal state | n2=en:general symptom | rel=r_associated | relid=0 | w=28
  76. en:terminal state -- r_associated #0: 28 / 0.651 -> en:glassy eyes
    n1=en:terminal state | n2=en:glassy eyes | rel=r_associated | relid=0 | w=28
  77. en:terminal state -- r_associated #0: 28 / 0.651 -> en:injection related reaction
    n1=en:terminal state | n2=en:injection related reaction | rel=r_associated | relid=0 | w=28
  78. en:terminal state -- r_associated #0: 28 / 0.651 -> en:organ failure
    n1=en:terminal state | n2=en:organ failure | rel=r_associated | relid=0 | w=28
  79. en:terminal state -- r_associated #0: 28 / 0.651 -> en:pre-existing condition improved
    n1=en:terminal state | n2=en:pre-existing condition improved | rel=r_associated | relid=0 | w=28
  80. en:terminal state -- r_associated #0: 28 / 0.651 -> en:reduced mobility
    n1=en:terminal state | n2=en:reduced mobility | rel=r_associated | relid=0 | w=28
  81. en:terminal state -- r_associated #0: 28 / 0.651 -> en:unmasking of previously unidentified disease
    n1=en:terminal state | n2=en:unmasking of previously unidentified disease | rel=r_associated | relid=0 | w=28
  82. en:terminal state -- r_associated #0: 28 / 0.651 -> phase terminale
    n1=en:terminal state | n2=phase terminale | rel=r_associated | relid=0 | w=28
  83. en:terminal state -- r_associated #0: 27 / 0.628 -> en:apparent death
    n1=en:terminal state | n2=en:apparent death | rel=r_associated | relid=0 | w=27
  84. en:terminal state -- r_associated #0: 27 / 0.628 -> en:congenital or acquired anatomic abnormality
    n1=en:terminal state | n2=en:congenital or acquired anatomic abnormality | rel=r_associated | relid=0 | w=27
  85. en:terminal state -- r_associated #0: 27 / 0.628 -> en:extravasation
    n1=en:terminal state | n2=en:extravasation | rel=r_associated | relid=0 | w=27
  86. en:terminal state -- r_associated #0: 27 / 0.628 -> en:general physical health deterioration
    n1=en:terminal state | n2=en:general physical health deterioration | rel=r_associated | relid=0 | w=27
  87. en:terminal state -- r_associated #0: 27 / 0.628 -> en:hot flashes
    n1=en:terminal state | n2=en:hot flashes | rel=r_associated | relid=0 | w=27
  88. en:terminal state -- r_associated #0: 27 / 0.628 -> en:increased energy
    n1=en:terminal state | n2=en:increased energy | rel=r_associated | relid=0 | w=27
  89. en:terminal state -- r_associated #0: 27 / 0.628 -> en:multi-organ disorder
    n1=en:terminal state | n2=en:multi-organ disorder | rel=r_associated | relid=0 | w=27
  90. en:terminal state -- r_associated #0: 27 / 0.628 -> en:pallor
    n1=en:terminal state | n2=en:pallor | rel=r_associated | relid=0 | w=27
  91. en:terminal state -- r_associated #0: 27 / 0.628 -> en:pre-existing condition
    n1=en:terminal state | n2=en:pre-existing condition | rel=r_associated | relid=0 | w=27
  92. en:terminal state -- r_associated #0: 26 / 0.605 -> bouffées de chaleur
    n1=en:terminal state | n2=bouffées de chaleur | rel=r_associated | relid=0 | w=26
  93. en:terminal state -- r_associated #0: 26 / 0.605 -> en:fat tissue decreased
    n1=en:terminal state | n2=en:fat tissue decreased | rel=r_associated | relid=0 | w=26
  94. en:terminal state -- r_associated #0: 26 / 0.605 -> en:flushing
    n1=en:terminal state | n2=en:flushing | rel=r_associated | relid=0 | w=26
  95. en:terminal state -- r_associated #0: 26 / 0.605 -> en:other ill-defined conditions
    n1=en:terminal state | n2=en:other ill-defined conditions | rel=r_associated | relid=0 | w=26
  96. en:terminal state -- r_associated #0: 26 / 0.605 -> en:swelling
    n1=en:terminal state | n2=en:swelling | rel=r_associated | relid=0 | w=26
  97. en:terminal state -- r_associated #0: 25 / 0.581 -> en:terminal
    n1=en:terminal state | n2=en:terminal | rel=r_associated | relid=0 | w=25
  98. en:terminal state -- r_associated #0: 23 / 0.535 -> sténose pathologique
    n1=en:terminal state | n2=sténose pathologique | rel=r_associated | relid=0 | w=23
  99. en:terminal state -- r_associated #0: 20 / 0.465 -> alvéolite
    n1=en:terminal state | n2=alvéolite | rel=r_associated | relid=0 | w=20
  100. en:terminal state -- r_associated #0: 20 / 0.465 -> anoxie tissulaire
    n1=en:terminal state | n2=anoxie tissulaire | rel=r_associated | relid=0 | w=20
  101. en:terminal state -- r_associated #0: 20 / 0.465 -> défaillance multi-viscérale
    n1=en:terminal state | n2=défaillance multi-viscérale | rel=r_associated | relid=0 | w=20
  102. en:terminal state -- r_associated #0: 20 / 0.465 -> défaillance multiviscérale
    n1=en:terminal state | n2=défaillance multiviscérale | rel=r_associated | relid=0 | w=20
  103. en:terminal state -- r_associated #0: 20 / 0.465 -> défaillance polyviscérale
    n1=en:terminal state | n2=défaillance polyviscérale | rel=r_associated | relid=0 | w=20
  104. en:terminal state -- r_associated #0: 20 / 0.465 -> des bouffées de chaleur
    n1=en:terminal state | n2=des bouffées de chaleur | rel=r_associated | relid=0 | w=20
  105. en:terminal state -- r_associated #0: 20 / 0.465 -> écoulement purulent
    n1=en:terminal state | n2=écoulement purulent | rel=r_associated | relid=0 | w=20
  106. en:terminal state -- r_associated #0: 20 / 0.465 -> empourpré
    n1=en:terminal state | n2=empourpré | rel=r_associated | relid=0 | w=20
  107. en:terminal state -- r_associated #0: 20 / 0.465 -> en:appearance of death
    n1=en:terminal state | n2=en:appearance of death | rel=r_associated | relid=0 | w=20
  108. en:terminal state -- r_associated #0: 20 / 0.465 -> en:final phase
    n1=en:terminal state | n2=en:final phase | rel=r_associated | relid=0 | w=20
  109. en:terminal state -- r_associated #0: 20 / 0.465 -> en:hot flushes
    n1=en:terminal state | n2=en:hot flushes | rel=r_associated | relid=0 | w=20
  110. en:terminal state -- r_associated #0: 20 / 0.465 -> en:ileus
    n1=en:terminal state | n2=en:ileus | rel=r_associated | relid=0 | w=20
  111. en:terminal state -- r_associated #0: 20 / 0.465 -> en:oncoma
    n1=en:terminal state | n2=en:oncoma | rel=r_associated | relid=0 | w=20
  112. en:terminal state -- r_associated #0: 20 / 0.465 -> en:pyorrhea
    n1=en:terminal state | n2=en:pyorrhea | rel=r_associated | relid=0 | w=20
  113. en:terminal state -- r_associated #0: 20 / 0.465 -> en:terminal stage
    n1=en:terminal state | n2=en:terminal stage | rel=r_associated | relid=0 | w=20
  114. en:terminal state -- r_associated #0: 20 / 0.465 -> en:tumefied
    n1=en:terminal state | n2=en:tumefied | rel=r_associated | relid=0 | w=20
  115. en:terminal state -- r_associated #0: 20 / 0.465 -> en:tumentia
    n1=en:terminal state | n2=en:tumentia | rel=r_associated | relid=0 | w=20
  116. en:terminal state -- r_associated #0: 20 / 0.465 -> en:xeroderma
    n1=en:terminal state | n2=en:xeroderma | rel=r_associated | relid=0 | w=20
  117. en:terminal state -- r_associated #0: 20 / 0.465 -> en:xerodermia
    n1=en:terminal state | n2=en:xerodermia | rel=r_associated | relid=0 | w=20
  118. en:terminal state -- r_associated #0: 20 / 0.465 -> enflé
    n1=en:terminal state | n2=enflé | rel=r_associated | relid=0 | w=20
  119. en:terminal state -- r_associated #0: 20 / 0.465 -> extravasation
    n1=en:terminal state | n2=extravasation | rel=r_associated | relid=0 | w=20
  120. en:terminal state -- r_associated #0: 20 / 0.465 -> Flushing
    n1=en:terminal state | n2=Flushing | rel=r_associated | relid=0 | w=20
  121. en:terminal state -- r_associated #0: 20 / 0.465 -> gonflement
    n1=en:terminal state | n2=gonflement | rel=r_associated | relid=0 | w=20
  122. en:terminal state -- r_associated #0: 20 / 0.465 -> hypohidrose
    n1=en:terminal state | n2=hypohidrose | rel=r_associated | relid=0 | w=20
  123. en:terminal state -- r_associated #0: 20 / 0.465 -> iléus
    n1=en:terminal state | n2=iléus | rel=r_associated | relid=0 | w=20
  124. en:terminal state -- r_associated #0: 20 / 0.465 -> ileus
    n1=en:terminal state | n2=ileus | rel=r_associated | relid=0 | w=20
  125. en:terminal state -- r_associated #0: 20 / 0.465 -> intumescence
    n1=en:terminal state | n2=intumescence | rel=r_associated | relid=0 | w=20
  126. en:terminal state -- r_associated #0: 20 / 0.465 -> macrosomie
    n1=en:terminal state | n2=macrosomie | rel=r_associated | relid=0 | w=20
  127. en:terminal state -- r_associated #0: 20 / 0.465 -> macrosomie, obésité, macrocéphalie et anomalies oculaires
    n1=en:terminal state | n2=macrosomie, obésité, macrocéphalie et anomalies oculaires | rel=r_associated | relid=0 | w=20
  128. en:terminal state -- r_associated #0: 20 / 0.465 -> météoropathie
    n1=en:terminal state | n2=météoropathie | rel=r_associated | relid=0 | w=20
  129. en:terminal state -- r_associated #0: 20 / 0.465 -> microlithiase
    n1=en:terminal state | n2=microlithiase | rel=r_associated | relid=0 | w=20
  130. en:terminal state -- r_associated #0: 20 / 0.465 -> MOMO (syndrome)
    n1=en:terminal state | n2=MOMO (syndrome) | rel=r_associated | relid=0 | w=20
  131. en:terminal state -- r_associated #0: 20 / 0.465 -> mort apparente
    n1=en:terminal state | n2=mort apparente | rel=r_associated | relid=0 | w=20
  132. en:terminal state -- r_associated #0: 20 / 0.465 -> prolapsus
    n1=en:terminal state | n2=prolapsus | rel=r_associated | relid=0 | w=20
  133. en:terminal state -- r_associated #0: 20 / 0.465 -> pseudo-kyste
    n1=en:terminal state | n2=pseudo-kyste | rel=r_associated | relid=0 | w=20
  134. en:terminal state -- r_associated #0: 20 / 0.465 -> pseudokyste
    n1=en:terminal state | n2=pseudokyste | rel=r_associated | relid=0 | w=20
  135. en:terminal state -- r_associated #0: 20 / 0.465 -> pyorrhée
    n1=en:terminal state | n2=pyorrhée | rel=r_associated | relid=0 | w=20
  136. en:terminal state -- r_associated #0: 20 / 0.465 -> râles
    n1=en:terminal state | n2=râles | rel=r_associated | relid=0 | w=20
  137. en:terminal state -- r_associated #0: 20 / 0.465 -> sténose
    n1=en:terminal state | n2=sténose | rel=r_associated | relid=0 | w=20
  138. en:terminal state -- r_associated #0: 20 / 0.465 -> stenosis
    n1=en:terminal state | n2=stenosis | rel=r_associated | relid=0 | w=20
  139. en:terminal state -- r_associated #0: 20 / 0.465 -> sueur froide
    n1=en:terminal state | n2=sueur froide | rel=r_associated | relid=0 | w=20
  140. en:terminal state -- r_associated #0: 20 / 0.465 -> sueurs nocturnes
    n1=en:terminal state | n2=sueurs nocturnes | rel=r_associated | relid=0 | w=20
  141. en:terminal state -- r_associated #0: 20 / 0.465 -> syndrome d'immobilisation
    n1=en:terminal state | n2=syndrome d'immobilisation | rel=r_associated | relid=0 | w=20
  142. en:terminal state -- r_associated #0: 20 / 0.465 -> syndrome de défaillance multiviscérale
    n1=en:terminal state | n2=syndrome de défaillance multiviscérale | rel=r_associated | relid=0 | w=20
  143. en:terminal state -- r_associated #0: 20 / 0.465 -> syndrome grippal
    n1=en:terminal state | n2=syndrome grippal | rel=r_associated | relid=0 | w=20
  144. en:terminal state -- r_associated #0: 20 / 0.465 -> tuméfaction
    n1=en:terminal state | n2=tuméfaction | rel=r_associated | relid=0 | w=20
  145. en:terminal state -- r_associated #0: 20 / 0.465 -> tuméfié
    n1=en:terminal state | n2=tuméfié | rel=r_associated | relid=0 | w=20
  146. en:terminal state -- r_associated #0: 20 / 0.465 -> tumescence
    n1=en:terminal state | n2=tumescence | rel=r_associated | relid=0 | w=20
  147. en:terminal state -- r_associated #0: 20 / 0.465 -> xeroderma
    n1=en:terminal state | n2=xeroderma | rel=r_associated | relid=0 | w=20
  148. en:terminal state -- r_associated #0: 20 / 0.465 -> xérodermie
    n1=en:terminal state | n2=xérodermie | rel=r_associated | relid=0 | w=20
  149. en:terminal state -- r_associated #0: 20 / 0.465 -> xérose
    n1=en:terminal state | n2=xérose | rel=r_associated | relid=0 | w=20
≈ 207 relations entrantes

  1. en:stenosis --- r_associated #0: 240 --> en:terminal state
    n1=en:stenosis | n2=en:terminal state | rel=r_associated | relid=0 | w=240
  2. sténose pathologique --- r_associated #0: 239 --> en:terminal state
    n1=sténose pathologique | n2=en:terminal state | rel=r_associated | relid=0 | w=239
  3. sténose --- r_associated #0: 210 --> en:terminal state
    n1=sténose | n2=en:terminal state | rel=r_associated | relid=0 | w=210
  4. défaillance polyviscérale --- r_associated #0: 192 --> en:terminal state
    n1=défaillance polyviscérale | n2=en:terminal state | rel=r_associated | relid=0 | w=192
  5. en:multiple organ failure --- r_associated #0: 185 --> en:terminal state
    n1=en:multiple organ failure | n2=en:terminal state | rel=r_associated | relid=0 | w=185
  6. défaillance multi-viscérale --- r_associated #0: 182 --> en:terminal state
    n1=défaillance multi-viscérale | n2=en:terminal state | rel=r_associated | relid=0 | w=182
  7. défaillance multiviscérale --- r_associated #0: 180 --> en:terminal state
    n1=défaillance multiviscérale | n2=en:terminal state | rel=r_associated | relid=0 | w=180
  8. syndrome de défaillance multiviscérale --- r_associated #0: 170 --> en:terminal state
    n1=syndrome de défaillance multiviscérale | n2=en:terminal state | rel=r_associated | relid=0 | w=170
  9. en:hot flashes --- r_associated #0: 149 --> en:terminal state
    n1=en:hot flashes | n2=en:terminal state | rel=r_associated | relid=0 | w=149
  10. bouffées de chaleur --- r_associated #0: 148 --> en:terminal state
    n1=bouffées de chaleur | n2=en:terminal state | rel=r_associated | relid=0 | w=148
  11. prolapsus --- r_associated #0: 131 --> en:terminal state
    n1=prolapsus | n2=en:terminal state | rel=r_associated | relid=0 | w=131
  12. en:prolapse --- r_associated #0: 127 --> en:terminal state
    n1=en:prolapse | n2=en:terminal state | rel=r_associated | relid=0 | w=127
  13. pyorrhée --- r_associated #0: 97 --> en:terminal state
    n1=pyorrhée | n2=en:terminal state | rel=r_associated | relid=0 | w=97
  14. en:purulent discharge --- r_associated #0: 96 --> en:terminal state
    n1=en:purulent discharge | n2=en:terminal state | rel=r_associated | relid=0 | w=96
  15. écoulement purulent --- r_associated #0: 95 --> en:terminal state
    n1=écoulement purulent | n2=en:terminal state | rel=r_associated | relid=0 | w=95
  16. météoropathie --- r_associated #0: 93 --> en:terminal state
    n1=météoropathie | n2=en:terminal state | rel=r_associated | relid=0 | w=93
  17. stenosis --- r_associated #0: 91 --> en:terminal state
    n1=stenosis | n2=en:terminal state | rel=r_associated | relid=0 | w=91
  18. en:meteoropathy --- r_associated #0: 89 --> en:terminal state
    n1=en:meteoropathy | n2=en:terminal state | rel=r_associated | relid=0 | w=89
  19. anoxie tissulaire --- r_associated #0: 86 --> en:terminal state
    n1=anoxie tissulaire | n2=en:terminal state | rel=r_associated | relid=0 | w=86
  20. en:tissue anoxia --- r_associated #0: 84 --> en:terminal state
    n1=en:tissue anoxia | n2=en:terminal state | rel=r_associated | relid=0 | w=84
  21. syndrome d'immobilisation --- r_associated #0: 80 --> en:terminal state
    n1=syndrome d'immobilisation | n2=en:terminal state | rel=r_associated | relid=0 | w=80
  22. en:disuse syndrome --- r_associated #0: 78 --> en:terminal state
    n1=en:disuse syndrome | n2=en:terminal state | rel=r_associated | relid=0 | w=78
  23. râles --- r_associated #0: 76 --> en:terminal state
    n1=râles | n2=en:terminal state | rel=r_associated | relid=0 | w=76
  24. en:rales --- r_associated #0: 72 --> en:terminal state
    n1=en:rales | n2=en:terminal state | rel=r_associated | relid=0 | w=72
  25. enflé --- r_associated #0: 56 --> en:terminal state
    n1=enflé | n2=en:terminal state | rel=r_associated | relid=0 | w=56
  26. pseudo-kyste --- r_associated #0: 56 --> en:terminal state
    n1=pseudo-kyste | n2=en:terminal state | rel=r_associated | relid=0 | w=56
  27. tuméfié --- r_associated #0: 55 --> en:terminal state
    n1=tuméfié | n2=en:terminal state | rel=r_associated | relid=0 | w=55
  28. pseudokyste --- r_associated #0: 54 --> en:terminal state
    n1=pseudokyste | n2=en:terminal state | rel=r_associated | relid=0 | w=54
  29. en:swelling --- r_associated #0: 51 --> en:terminal state
    n1=en:swelling | n2=en:terminal state | rel=r_associated | relid=0 | w=51
  30. xérodermie --- r_associated #0: 50 --> en:terminal state
    n1=xérodermie | n2=en:terminal state | rel=r_associated | relid=0 | w=50
  31. iléus --- r_associated #0: 49 --> en:terminal state
    n1=iléus | n2=en:terminal state | rel=r_associated | relid=0 | w=49
  32. en:xerosis --- r_associated #0: 48 --> en:terminal state
    n1=en:xerosis | n2=en:terminal state | rel=r_associated | relid=0 | w=48
  33. syndrome grippal --- r_associated #0: 47 --> en:terminal state
    n1=syndrome grippal | n2=en:terminal state | rel=r_associated | relid=0 | w=47
  34. xérose --- r_associated #0: 46 --> en:terminal state
    n1=xérose | n2=en:terminal state | rel=r_associated | relid=0 | w=46
  35. en:extravasation --- r_associated #0: 45 --> en:terminal state
    n1=en:extravasation | n2=en:terminal state | rel=r_associated | relid=0 | w=45
  36. en:ileus --- r_associated #0: 45 --> en:terminal state
    n1=en:ileus | n2=en:terminal state | rel=r_associated | relid=0 | w=45
  37. en:pyorrhea --- r_associated #0: 44 --> en:terminal state
    n1=en:pyorrhea | n2=en:terminal state | rel=r_associated | relid=0 | w=44
  38. en:developmental regression --- r_associated #0: 43 --> en:terminal state
    n1=en:developmental regression | n2=en:terminal state | rel=r_associated | relid=0 | w=43
  39. en:pseudocyst --- r_associated #0: 43 --> en:terminal state
    n1=en:pseudocyst | n2=en:terminal state | rel=r_associated | relid=0 | w=43
  40. ileus --- r_associated #0: 43 --> en:terminal state
    n1=ileus | n2=en:terminal state | rel=r_associated | relid=0 | w=43
  41. en:xeroderma --- r_associated #0: 41 --> en:terminal state
    n1=en:xeroderma | n2=en:terminal state | rel=r_associated | relid=0 | w=41
  42. extravasation --- r_associated #0: 41 --> en:terminal state
    n1=extravasation | n2=en:terminal state | rel=r_associated | relid=0 | w=41
  43. en:concomitant disease aggravated --- r_associated #0: 40 --> en:terminal state
    n1=en:concomitant disease aggravated | n2=en:terminal state | rel=r_associated | relid=0 | w=40
  44. en:hot flushes --- r_associated #0: 40 --> en:terminal state
    n1=en:hot flushes | n2=en:terminal state | rel=r_associated | relid=0 | w=40
  45. en:terminal agitation --- r_associated #0: 40 --> en:terminal state
    n1=en:terminal agitation | n2=en:terminal state | rel=r_associated | relid=0 | w=40
  46. en:flushing --- r_associated #0: 39 --> en:terminal state
    n1=en:flushing | n2=en:terminal state | rel=r_associated | relid=0 | w=39
  47. xeroderma --- r_associated #0: 39 --> en:terminal state
    n1=xeroderma | n2=en:terminal state | rel=r_associated | relid=0 | w=39
  48. alvéolite --- r_associated #0: 38 --> en:terminal state
    n1=alvéolite | n2=en:terminal state | rel=r_associated | relid=0 | w=38
  49. MOMO (syndrome) --- r_associated #0: 36 --> en:terminal state
    n1=MOMO (syndrome) | n2=en:terminal state | rel=r_associated | relid=0 | w=36
  50. macrosomie --- r_associated #0: 36 --> en:terminal state
    n1=macrosomie | n2=en:terminal state | rel=r_associated | relid=0 | w=36
  51. sueur froide --- r_associated #0: 36 --> en:terminal state
    n1=sueur froide | n2=en:terminal state | rel=r_associated | relid=0 | w=36
  52. tumescence --- r_associated #0: 36 --> en:terminal state
    n1=tumescence | n2=en:terminal state | rel=r_associated | relid=0 | w=36
  53. en:adipose tissue deposition --- r_associated #0: 35 --> en:terminal state
    n1=en:adipose tissue deposition | n2=en:terminal state | rel=r_associated | relid=0 | w=35
  54. en:body substance discharge --- r_associated #0: 35 --> en:terminal state
    n1=en:body substance discharge | n2=en:terminal state | rel=r_associated | relid=0 | w=35
  55. en:infected fistula --- r_associated #0: 35 --> en:terminal state
    n1=en:infected fistula | n2=en:terminal state | rel=r_associated | relid=0 | w=35
  56. en:local reaction --- r_associated #0: 35 --> en:terminal state
    n1=en:local reaction | n2=en:terminal state | rel=r_associated | relid=0 | w=35
  57. en:obstruction --- r_associated #0: 35 --> en:terminal state
    n1=en:obstruction | n2=en:terminal state | rel=r_associated | relid=0 | w=35
  58. en:premature aging syndrome --- r_associated #0: 35 --> en:terminal state
    n1=en:premature aging syndrome | n2=en:terminal state | rel=r_associated | relid=0 | w=35
  59. en:yellow complexion --- r_associated #0: 35 --> en:terminal state
    n1=en:yellow complexion | n2=en:terminal state | rel=r_associated | relid=0 | w=35
  60. gonflement --- r_associated #0: 35 --> en:terminal state
    n1=gonflement | n2=en:terminal state | rel=r_associated | relid=0 | w=35
  61. intumescence --- r_associated #0: 35 --> en:terminal state
    n1=intumescence | n2=en:terminal state | rel=r_associated | relid=0 | w=35
  62. tuméfaction --- r_associated #0: 35 --> en:terminal state
    n1=tuméfaction | n2=en:terminal state | rel=r_associated | relid=0 | w=35
  63. en:autoresuscitation --- r_associated #0: 34 --> en:terminal state
    n1=en:autoresuscitation | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  64. en:cold sweat --- r_associated #0: 34 --> en:terminal state
    n1=en:cold sweat | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  65. en:death imminent --- r_associated #0: 34 --> en:terminal state
    n1=en:death imminent | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  66. en:fat tissue decreased --- r_associated #0: 34 --> en:terminal state
    n1=en:fat tissue decreased | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  67. en:fistula discharge --- r_associated #0: 34 --> en:terminal state
    n1=en:fistula discharge | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  68. en:foaming at mouth --- r_associated #0: 34 --> en:terminal state
    n1=en:foaming at mouth | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  69. en:performance status decreased --- r_associated #0: 34 --> en:terminal state
    n1=en:performance status decreased | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  70. en:peripheral swelling --- r_associated #0: 34 --> en:terminal state
    n1=en:peripheral swelling | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  71. en:symptom masked --- r_associated #0: 34 --> en:terminal state
    n1=en:symptom masked | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  72. en:tissue adhesion --- r_associated #0: 34 --> en:terminal state
    n1=en:tissue adhesion | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  73. phase terminale --- r_associated #0: 34 --> en:terminal state
    n1=phase terminale | n2=en:terminal state | rel=r_associated | relid=0 | w=34
  74. en:hypohidrosis --- r_associated #0: 32 --> en:terminal state
    n1=en:hypohidrosis | n2=en:terminal state | rel=r_associated | relid=0 | w=32
  75. en:irritation --- r_associated #0: 32 --> en:terminal state
    n1=en:irritation | n2=en:terminal state | rel=r_associated | relid=0 | w=32
  76. en:macrosomia --- r_associated #0: 32 --> en:terminal state
    n1=en:macrosomia | n2=en:terminal state | rel=r_associated | relid=0 | w=32
  77. en:microlithiasis --- r_associated #0: 32 --> en:terminal state
    n1=en:microlithiasis | n2=en:terminal state | rel=r_associated | relid=0 | w=32
  78. en:reduced mobility --- r_associated #0: 32 --> en:terminal state
    n1=en:reduced mobility | n2=en:terminal state | rel=r_associated | relid=0 | w=32
  79. en:terminal stage --- r_associated #0: 32 --> en:terminal state
    n1=en:terminal stage | n2=en:terminal state | rel=r_associated | relid=0 | w=32
  80. microlithiase --- r_associated #0: 32 --> en:terminal state
    n1=microlithiase | n2=en:terminal state | rel=r_associated | relid=0 | w=32
  81. en:decreased exercise tolerance --- r_associated #0: 31 --> en:terminal state
    n1=en:decreased exercise tolerance | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  82. en:developmental delay --- r_associated #0: 31 --> en:terminal state
    n1=en:developmental delay | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  83. en:disease complication --- r_associated #0: 31 --> en:terminal state
    n1=en:disease complication | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  84. en:general symptom --- r_associated #0: 31 --> en:terminal state
    n1=en:general symptom | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  85. en:hyperhidrosis --- r_associated #0: 31 --> en:terminal state
    n1=en:hyperhidrosis | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  86. en:impaired self-care --- r_associated #0: 31 --> en:terminal state
    n1=en:impaired self-care | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  87. en:irritability post vac --- r_associated #0: 31 --> en:terminal state
    n1=en:irritability post vac | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  88. en:unmasking of previously unidentified disease --- r_associated #0: 31 --> en:terminal state
    n1=en:unmasking of previously unidentified disease | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  89. hypohidrose --- r_associated #0: 31 --> en:terminal state
    n1=hypohidrose | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  90. mort apparente --- r_associated #0: 31 --> en:terminal state
    n1=mort apparente | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  91. sueurs nocturnes --- r_associated #0: 31 --> en:terminal state
    n1=sueurs nocturnes | n2=en:terminal state | rel=r_associated | relid=0 | w=31
  92. empourpré --- r_associated #0: 30 --> en:terminal state
    n1=empourpré | n2=en:terminal state | rel=r_associated | relid=0 | w=30
  93. en:apparent death --- r_associated #0: 30 --> en:terminal state
    n1=en:apparent death | n2=en:terminal state | rel=r_associated | relid=0 | w=30
  94. en:appearance of death --- r_associated #0: 30 --> en:terminal state
    n1=en:appearance of death | n2=en:terminal state | rel=r_associated | relid=0 | w=30
  95. en:concomitant disease progression --- r_associated #0: 30 --> en:terminal state
    n1=en:concomitant disease progression | n2=en:terminal state | rel=r_associated | relid=0 | w=30
  96. en:disease progression --- r_associated #0: 30 --> en:terminal state
    n1=en:disease progression | n2=en:terminal state | rel=r_associated | relid=0 | w=30
  97. en:disease recurrence --- r_associated #0: 30 --> en:terminal state
    n1=en:disease recurrence | n2=en:terminal state | rel=r_associated | relid=0 | w=30
  98. en:glassy eyes --- r_associated #0: 30 --> en:terminal state
    n1=en:glassy eyes | n2=en:terminal state | rel=r_associated | relid=0 | w=30
  99. en:induration --- r_associated #0: 30 --> en:terminal state
    n1=en:induration | n2=en:terminal state | rel=r_associated | relid=0 | w=30
  100. en:pre-existing condition improved --- r_associated #0: 30 --> en:terminal state
    n1=en:pre-existing condition improved | n2=en:terminal state | rel=r_associated | relid=0 | w=30
  101. en:bloody discharge --- r_associated #0: 29 --> en:terminal state
    n1=en:bloody discharge | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  102. en:chronic disease --- r_associated #0: 29 --> en:terminal state
    n1=en:chronic disease | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  103. en:critical illness --- r_associated #0: 29 --> en:terminal state
    n1=en:critical illness | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  104. en:exercise tolerance increased --- r_associated #0: 29 --> en:terminal state
    n1=en:exercise tolerance increased | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  105. en:fetal growth retardation --- r_associated #0: 29 --> en:terminal state
    n1=en:fetal growth retardation | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  106. en:general physical health deterioration --- r_associated #0: 29 --> en:terminal state
    n1=en:general physical health deterioration | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  107. en:general signs and symptoms nec --- r_associated #0: 29 --> en:terminal state
    n1=en:general signs and symptoms nec | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  108. en:inflammatory fistula --- r_associated #0: 29 --> en:terminal state
    n1=en:inflammatory fistula | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  109. en:local swelling --- r_associated #0: 29 --> en:terminal state
    n1=en:local swelling | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  110. en:multi-organ disorder --- r_associated #0: 29 --> en:terminal state
    n1=en:multi-organ disorder | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  111. en:pre-existing condition --- r_associated #0: 29 --> en:terminal state
    n1=en:pre-existing condition | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  112. en:reaction nonspecific --- r_associated #0: 29 --> en:terminal state
    n1=en:reaction nonspecific | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  113. en:sensitivity to weather change --- r_associated #0: 29 --> en:terminal state
    n1=en:sensitivity to weather change | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  114. en:sick building syndrome --- r_associated #0: 29 --> en:terminal state
    n1=en:sick building syndrome | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  115. en:tumefied --- r_associated #0: 29 --> en:terminal state
    n1=en:tumefied | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  116. macrocéphalie --- r_associated #0: 29 --> en:terminal state
    n1=macrocéphalie | n2=en:terminal state | rel=r_associated | relid=0 | w=29
  117. des bouffées de chaleur --- r_associated #0: 28 --> en:terminal state
    n1=des bouffées de chaleur | n2=en:terminal state | rel=r_associated | relid=0 | w=28
  118. en:oncoma --- r_associated #0: 28 --> en:terminal state
    n1=en:oncoma | n2=en:terminal state | rel=r_associated | relid=0 | w=28
  119. en:organ failure --- r_associated #0: 28 --> en:terminal state
    n1=en:organ failure | n2=en:terminal state | rel=r_associated | relid=0 | w=28
  120. en:perforation --- r_associated #0: 28 --> en:terminal state
    n1=en:perforation | n2=en:terminal state | rel=r_associated | relid=0 | w=28
  121. en:post cardiac arrest syndrome --- r_associated #0: 28 --> en:terminal state
    n1=en:post cardiac arrest syndrome | n2=en:terminal state | rel=r_associated | relid=0 | w=28
  122. en:sucking, thumb --- r_associated #0: 28 --> en:terminal state
    n1=en:sucking, thumb | n2=en:terminal state | rel=r_associated | relid=0 | w=28
  123. en:effusion --- r_associated #0: 27 --> en:terminal state
    n1=en:effusion | n2=en:terminal state | rel=r_associated | relid=0 | w=27
  124. en:increased energy --- r_associated #0: 27 --> en:terminal state
    n1=en:increased energy | n2=en:terminal state | rel=r_associated | relid=0 | w=27
  125. en:influenza-like illness --- r_associated #0: 27 --> en:terminal state
    n1=en:influenza-like illness | n2=en:terminal state | rel=r_associated | relid=0 | w=27
  126. en:injection related reaction --- r_associated #0: 27 --> en:terminal state
    n1=en:injection related reaction | n2=en:terminal state | rel=r_associated | relid=0 | w=27
  127. en:night sweats --- r_associated #0: 27 --> en:terminal state
    n1=en:night sweats | n2=en:terminal state | rel=r_associated | relid=0 | w=27
  128. en:susceptibility --- r_associated #0: 27 --> en:terminal state
    n1=en:susceptibility | n2=en:terminal state | rel=r_associated | relid=0 | w=27
  129. en:xerodermia --- r_associated #0: 27 --> en:terminal state
    n1=en:xerodermia | n2=en:terminal state | rel=r_associated | relid=0 | w=27
  130. macrosomie, obésité, macrocéphalie et anomalies oculaires --- r_associated #0: 27 --> en:terminal state
    n1=macrosomie, obésité, macrocéphalie et anomalies oculaires | n2=en:terminal state | rel=r_associated | relid=0 | w=27
  131. Flushing --- r_associated #0: 26 --> en:terminal state
    n1=Flushing | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  132. en:administration related reaction --- r_associated #0: 26 --> en:terminal state
    n1=en:administration related reaction | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  133. en:condition aggravated --- r_associated #0: 26 --> en:terminal state
    n1=en:condition aggravated | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  134. en:congenital or acquired anatomic abnormality --- r_associated #0: 26 --> en:terminal state
    n1=en:congenital or acquired anatomic abnormality | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  135. en:difficulty standing --- r_associated #0: 26 --> en:terminal state
    n1=en:difficulty standing | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  136. en:final phase --- r_associated #0: 26 --> en:terminal state
    n1=en:final phase | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  137. en:infusion-related reaction --- r_associated #0: 26 --> en:terminal state
    n1=en:infusion-related reaction | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  138. en:multimorbidities --- r_associated #0: 26 --> en:terminal state
    n1=en:multimorbidities | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  139. en:other ill-defined conditions --- r_associated #0: 26 --> en:terminal state
    n1=en:other ill-defined conditions | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  140. en:pneumatosis --- r_associated #0: 26 --> en:terminal state
    n1=en:pneumatosis | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  141. en:tumentia --- r_associated #0: 26 --> en:terminal state
    n1=en:tumentia | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  142. en:unevaluable event --- r_associated #0: 26 --> en:terminal state
    n1=en:unevaluable event | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  143. en:wound discharge --- r_associated #0: 26 --> en:terminal state
    n1=en:wound discharge | n2=en:terminal state | rel=r_associated | relid=0 | w=26
  144. défaillance viscérale --- r_associated #0: 25 --> en:terminal state
    n1=défaillance viscérale | n2=en:terminal state | rel=r_associated | relid=0 | w=25
  145. en:MOF --- r_associated #0: 25 --> en:terminal state
    n1=en:MOF | n2=en:terminal state | rel=r_associated | relid=0 | w=25
  146. en:multiple organ dysfunction syndrome --- r_associated #0: 25 --> en:terminal state
    n1=en:multiple organ dysfunction syndrome | n2=en:terminal state | rel=r_associated | relid=0 | w=25
  147. en:multisystem organ failure --- r_associated #0: 25 --> en:terminal state
    n1=en:multisystem organ failure | n2=en:terminal state | rel=r_associated | relid=0 | w=25
  148. en:neonatal multi-organ failure --- r_associated #0: 25 --> en:terminal state
    n1=en:neonatal multi-organ failure | n2=en:terminal state | rel=r_associated | relid=0 | w=25
  149. TULV --- r_associated #0: 24 --> en:terminal state
    n1=TULV | n2=en:terminal state | rel=r_associated | relid=0 | w=24
  150. en:Flushing --- r_associated #0: 24 --> en:terminal state
    n1=en:Flushing | n2=en:terminal state | rel=r_associated | relid=0 | w=24
  151. en:macrocephaly --- r_associated #0: 24 --> en:terminal state
    n1=en:macrocephaly | n2=en:terminal state | rel=r_associated | relid=0 | w=24
  152. en:oncosis --- r_associated #0: 24 --> en:terminal state
    n1=en:oncosis | n2=en:terminal state | rel=r_associated | relid=0 | w=24
  153. hyperhidrose --- r_associated #0: 24 --> en:terminal state
    n1=hyperhidrose | n2=en:terminal state | rel=r_associated | relid=0 | w=24
  154. en:crying --- r_associated #0: 23 --> en:terminal state
    n1=en:crying | n2=en:terminal state | rel=r_associated | relid=0 | w=23
  155. en:prolapsus --- r_associated #0: 23 --> en:terminal state
    n1=en:prolapsus | n2=en:terminal state | rel=r_associated | relid=0 | w=23
  156. en:dark circles under eyes --- r_associated #0: 22 --> en:terminal state
    n1=en:dark circles under eyes | n2=en:terminal state | rel=r_associated | relid=0 | w=22
  157. en:disease prodromal stage --- r_associated #0: 22 --> en:terminal state
    n1=en:disease prodromal stage | n2=en:terminal state | rel=r_associated | relid=0 | w=22
  158. en:pallor --- r_associated #0: 22 --> en:terminal state
    n1=en:pallor | n2=en:terminal state | rel=r_associated | relid=0 | w=22
  159. bouffées de chaleur accompagnée de sueurs --- r_associated #0: 21 --> en:terminal state
    n1=bouffées de chaleur accompagnée de sueurs | n2=en:terminal state | rel=r_associated | relid=0 | w=21
  160. en:obesity --- r_associated #0: 21 --> en:terminal state
    n1=en:obesity | n2=en:terminal state | rel=r_associated | relid=0 | w=21
  161. en:serum sickness-like reaction --- r_associated #0: 21 --> en:terminal state
    n1=en:serum sickness-like reaction | n2=en:terminal state | rel=r_associated | relid=0 | w=21
  162. mobilité réduite --- r_associated #0: 21 --> en:terminal state
    n1=mobilité réduite | n2=en:terminal state | rel=r_associated | relid=0 | w=21
  163. rétrécissement --- r_associated #0: 21 --> en:terminal state
    n1=rétrécissement | n2=en:terminal state | rel=r_associated | relid=0 | w=21
  164. Sténose --- r_associated #0: 20 --> en:terminal state
    n1=Sténose | n2=en:terminal state | rel=r_associated | relid=0 | w=20
  165. Mobilité réduite --- r_associated #0: 15 --> en:terminal state
    n1=Mobilité réduite | n2=en:terminal state | rel=r_associated | relid=0 | w=15
  166. Mort apparente --- r_associated #0: 15 --> en:terminal state
    n1=Mort apparente | n2=en:terminal state | rel=r_associated | relid=0 | w=15
  167. Prolapsus --- r_associated #0: 15 --> en:terminal state
    n1=Prolapsus | n2=en:terminal state | rel=r_associated | relid=0 | w=15
  168. Syndrome grippal --- r_associated #0: 15 --> en:terminal state
    n1=Syndrome grippal | n2=en:terminal state | rel=r_associated | relid=0 | w=15
  169. Tuméfaction --- r_associated #0: 15 --> en:terminal state
    n1=Tuméfaction | n2=en:terminal state | rel=r_associated | relid=0 | w=15
  170. déefférentation motrice (syndrome de) --- r_associated #0: 15 --> en:terminal state
    n1=déefférentation motrice (syndrome de) | n2=en:terminal state | rel=r_associated | relid=0 | w=15
  171. hyperidrose --- r_associated #0: 15 --> en:terminal state
    n1=hyperidrose | n2=en:terminal state | rel=r_associated | relid=0 | w=15
  172. obésité --- r_associated #0: 15 --> en:terminal state
    n1=obésité | n2=en:terminal state | rel=r_associated | relid=0 | w=15
  173. Bouffées de chaleur --- r_associated #0: 10 --> en:terminal state
    n1=Bouffées de chaleur | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  174. Ilesha (virus) --- r_associated #0: 10 --> en:terminal state
    n1=Ilesha (virus) | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  175. Iléus --- r_associated #0: 10 --> en:terminal state
    n1=Iléus | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  176. Pseudo-kyste --- r_associated #0: 10 --> en:terminal state
    n1=Pseudo-kyste | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  177. Pseudokyste --- r_associated #0: 10 --> en:terminal state
    n1=Pseudokyste | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  178. Rétrécissement --- r_associated #0: 10 --> en:terminal state
    n1=Rétrécissement | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  179. Syndrome de défaillance multiviscérale --- r_associated #0: 10 --> en:terminal state
    n1=Syndrome de défaillance multiviscérale | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  180. Tula (virus) --- r_associated #0: 10 --> en:terminal state
    n1=Tula (virus) | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  181. Tumarkin (vertige de) --- r_associated #0: 10 --> en:terminal state
    n1=Tumarkin (vertige de) | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  182. Xeroderma --- r_associated #0: 10 --> en:terminal state
    n1=Xeroderma | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  183. bouffée de chaleur --- r_associated #0: 10 --> en:terminal state
    n1=bouffée de chaleur | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  184. curage --- r_associated #0: 10 --> en:terminal state
    n1=curage | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  185. en:and ocular abnormalities --- r_associated #0: 10 --> en:terminal state
    n1=en:and ocular abnormalities | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  186. en:and ocular abnormalities syndrome --- r_associated #0: 10 --> en:terminal state
    n1=en:and ocular abnormalities syndrome | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  187. en:end stage --- r_associated #0: 10 --> en:terminal state
    n1=en:end stage | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  188. en:narrowing down --- r_associated #0: 10 --> en:terminal state
    n1=en:narrowing down | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  189. en:periodontitis --- r_associated #0: 10 --> en:terminal state
    n1=en:periodontitis | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  190. flushing --- r_associated #0: 10 --> en:terminal state
    n1=flushing | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  191. maladie des grands ensembles --- r_associated #0: 10 --> en:terminal state
    n1=maladie des grands ensembles | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  192. mort (signes de la) --- r_associated #0: 10 --> en:terminal state
    n1=mort (signes de la) | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  193. retards de croissance et de développement avec dysmorphie faciale --- r_associated #0: 10 --> en:terminal state
    n1=retards de croissance et de développement avec dysmorphie faciale | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  194. retraite (troubles psychiques et) --- r_associated #0: 10 --> en:terminal state
    n1=retraite (troubles psychiques et) | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  195. syndrome des bâtiments malsains --- r_associated #0: 10 --> en:terminal state
    n1=syndrome des bâtiments malsains | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  196. syndrome du bâtiment malsain --- r_associated #0: 10 --> en:terminal state
    n1=syndrome du bâtiment malsain | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  197. tumeur --- r_associated #0: 10 --> en:terminal state
    n1=tumeur | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  198. tumeur à cellules claires --- r_associated #0: 10 --> en:terminal state
    n1=tumeur à cellules claires | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  199. tumeur à cellules claires de l'ovaire --- r_associated #0: 10 --> en:terminal state
    n1=tumeur à cellules claires de l'ovaire | n2=en:terminal state | rel=r_associated | relid=0 | w=10
  200. Macrocéphalie --- r_associated #0: 5 --> en:terminal state
    n1=Macrocéphalie | n2=en:terminal state | rel=r_associated | relid=0 | w=5
  201. Sueurs nocturnes --- r_associated #0: 5 --> en:terminal state
    n1=Sueurs nocturnes | n2=en:terminal state | rel=r_associated | relid=0 | w=5
  202. Xérodermie --- r_associated #0: 5 --> en:terminal state
    n1=Xérodermie | n2=en:terminal state | rel=r_associated | relid=0 | w=5
  203. défaillance autonomique progressive --- r_associated #0: 5 --> en:terminal state
    n1=défaillance autonomique progressive | n2=en:terminal state | rel=r_associated | relid=0 | w=5
  204. défaillance cardiaque --- r_associated #0: 5 --> en:terminal state
    n1=défaillance cardiaque | n2=en:terminal state | rel=r_associated | relid=0 | w=5
  205. défaillance psychique sénile --- r_associated #0: 5 --> en:terminal state
    n1=défaillance psychique sénile | n2=en:terminal state | rel=r_associated | relid=0 | w=5
  206. microgéodes phalangiennes (syndrome des) --- r_associated #0: 5 --> en:terminal state
    n1=microgéodes phalangiennes (syndrome des) | n2=en:terminal state | rel=r_associated | relid=0 | w=5
  207. syndrome de déefférentation motrice --- r_associated #0: 5 --> en:terminal state
    n1=syndrome de déefférentation motrice | n2=en:terminal state | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr